Files
Abstract
Methamphetamine-associated heart failure (MethHF) is quickly becoming a recognized healthcare problem with devastating patient and societal impact, especially in the state of Oregon, which has the highest rate of methamphetamine abuse in the US. However, our understanding of this phenomenon is very limited. We aimed to describe the sociodemographic and clinical characteristics of patients hospitalized with MethHF as compared with patients hospitalized with HF but not using methamphetamine.